| Active substance | Sparsentan |
| Holder | Bionical Emas T/A Bionical Limited (on behalf of Vifor (International)AG) |
| Status | Running |
| Indication | Treatment in adults with primary immunoglobulin A nephropathy (IgAN) with a urine protein excretion >1g/day |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent | |
| Last update | 19/10/2023 |